{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,9,17]],"date-time":"2023-09-17T13:13:10Z","timestamp":1694956390946},"reference-count":29,"publisher":"Japanese Society of Internal Medicine","issue":"18","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2023,9,15]]},"DOI":"10.2169\/internalmedicine.2115-23","type":"journal-article","created":{"date-parts":[[2023,7,4]],"date-time":"2023-07-04T22:12:30Z","timestamp":1688508750000},"page":"2617-2625","source":"Crossref","is-referenced-by-count":0,"title":["The Impact of Liver Chemistries on Respiratory Failure among Hemodialysis Patients with COVID-19 during the Omicron Wave"],"prefix":"10.2169","volume":"62","author":[{"given":"Mayuko","family":"Hori","sequence":"first","affiliation":[{"name":"Department of Nephrology, Masuko Memorial Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kaoru","family":"Yasuda","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Masuko Memorial Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Takahashi","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Fujita Health University School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomonori","family":"Aoi","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Masuko Memorial Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshiko","family":"Mori","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Masuko Memorial Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Makoto","family":"Tsujita","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Masuko Memorial Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuichi","family":"Shirasawa","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Masuko Memorial Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chika","family":"Kondo","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Masuko Memorial Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Hashimoto","sequence":"additional","affiliation":[{"name":"Department of General Internal Medicine, Masuko Memorial Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroichi","family":"Koyama","sequence":"additional","affiliation":[{"name":"Department of General Internal Medicine, Masuko Memorial Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kunio","family":"Morozumi","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Masuko Memorial Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shoichi","family":"Maruyama","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Nagoya University Graduate School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1","unstructured":"1. Li Q, Guan X, Wu P, et al. Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia. N Engl J Med 382: 1199-1207, 2020."},{"key":"2","doi-asserted-by":"publisher","unstructured":"2. Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 395: 497-506, 2020.","DOI":"10.1016\/S0140-6736(20)30183-5"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Guan WJ, Ni ZY, Hu Y, et al. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med 382: 1708-1720, 2020.","DOI":"10.1056\/NEJMoa2002032"},{"key":"4","unstructured":"4. Ding Z-Y, Li G-X, Chen L, et al. Association of liver abnormalities with in-hospital mortality in patients with COVID-19. J Hepatol 74: 1295-1302, 2021."},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Hsu CM, Weiner DE, Aweh G, et al. COVID-19 among US dialysis patients: risk factors and outcomes from a national dialysis provider. Am J Kidney Dis 77: 748-756.e741, 2021.","DOI":"10.1053\/j.ajkd.2021.01.003"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Chung EY, Palmer SC, Natale P, et al. Incidence and outcomes of COVID-19 in people with CKD: a systematic review and meta-analysis. Am J Kidney Dis 78: 804-815, 2021.","DOI":"10.1053\/j.ajkd.2021.07.003"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Callaway E, Ledford H. How bad is Omicron? What scientists know so far. Nature 600: 197-199, 2021.","DOI":"10.1038\/d41586-021-03614-z"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Liu J, Huang Z, Gilbertson DT, Foley RN, Collins AJ. An improved comorbidity index for outcome analyses among dialysis patients. Kidney Int 77: 141-151, 2010.","DOI":"10.1038\/ki.2009.413"},{"key":"9","unstructured":"9. Ministry of Health, Labour, and Welfare in Japan. Clinical management of patients with COVID-19: a guide for front-line healthcare workers. Tokyo, Japan, 2020: 33-59."},{"key":"10","doi-asserted-by":"publisher","unstructured":"10. DeLong ER, DeLong DM, Clarke-Pearson DL. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics 44: 837-845, 1988.","DOI":"10.2307\/2531595"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Pencina MJ, D&apos;Agostino RB Sr, D&apos;Agostino RB Jr, Vasan RS. Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond. Stat Med 27: 157-172, 2008.","DOI":"10.1002\/sim.2929"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Jassat W, Abdool Karim SS, Mudara C, et al. Clinical severity of COVID-19 in patients admitted to hospital during the Omicron wave in South Africa: a retrospective observational study. Lancet Glob Health 10: e961-e969, 2022.","DOI":"10.1016\/S2214-109X(22)00114-0"},{"key":"13","unstructured":"13. Halfmann PJ, Iida S, Iwatsuki-Horimoto K, et al. SARS-CoV-2 Omicron virus causes attenuated disease in mice and hamsters. Nature 603: 687-692, 2022."},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Hui KPY, Ho JCW, Cheung MC, et al. SARS-CoV-2 Omicron variant replication in human bronchus and lung <i>ex vivo<\/i>. Nature 603: 715-720, 2022.","DOI":"10.1038\/s41586-022-04479-6"},{"key":"15","unstructured":"15. Meng B, Abdullahi A, Ferreira I, et al. Altered TMPRSS2 usage by SARS-CoV-2 Omicron impacts infectivity and fusogenicity. Nature 603: 706-714, 2022."},{"key":"16","unstructured":"16. National Institute of Infectious Diseases in Japan. About the new coronavirus vaccine [Internet]. 2022 Jan 14 [cited 2022 Oct 10]. Available from: https:\/\/www.niid.go.jp\/niid\/ja\/2019-ncov\/2484-idsc\/10923-covid19-68.html"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Haruta M, Otsubo S, Otsubo Y. Characteristics of the 6th Japanese wave of COVID-19 in hemodialysis patients. Ren Replace Ther 8: 61, 2022.","DOI":"10.1186\/s41100-022-00451-2"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Mayr FB, Talisa VB, Castro AD, Shaikh OS, Omer SB, Butt AA. COVID-19 disease severity in US veterans infected during Omicron and Delta variant predominant periods. Nat Commun 13: 3647, 2022.","DOI":"10.1038\/s41467-022-31402-4"},{"key":"19","doi-asserted-by":"publisher","unstructured":"19. Maslo C, Friedland R, Toubkin M, Laubscher A, Akaloo T, Kama B. Characteristics and outcomes of hospitalized patients in South Africa during the COVID-19 omicron wave compared with previous waves. JAMA 327: 583-584, 2022.","DOI":"10.1001\/jama.2021.24868"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Xie J, Covassin N, Fan Z, et al. Association between hypoxemia and mortality in patients with COVID-19. Mayo Clin Proc 95: 1138-1147, 2020.","DOI":"10.1016\/j.mayocp.2020.04.006"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Feng Z, Yu Q, Yao S, et al. Early prediction of disease progression in COVID-19 pneumonia patients with chest CT and clinical characteristics. Nat Commun 11: 4968, 2020.","DOI":"10.1038\/s41467-020-18786-x"},{"key":"22","doi-asserted-by":"publisher","unstructured":"22. Liu F, Zhang Q, Huang C, et al. CT quantification of pneumonia lesions in early days predicts progression to severe illness in a cohort of COVID-19 patients. Theranostics 10: 5613-5622, 2020.","DOI":"10.7150\/thno.45985"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Nardo AD, Schneeweiss-Gleixner M, Bakail M, Dixon ED, Lax SF, Trauner M. Pathophysiological mechanisms of liver injury in COVID-19. Liver Int 41: 20-32, 2021.","DOI":"10.1111\/liv.14730"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Wu J, Song S, Cao HC, Li LJ. Liver diseases in COVID-19: etiology, treatment and prognosis. World J Gastroenterol 26: 2286-2293, 2020.","DOI":"10.3748\/wjg.v26.i19.2286"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Fabrizi F, Lunghi G, Finazzi S, et al. Decreased serum aminotransferase activity in patients with chronic renal failure: impact on the detection of viral hepatitis. Am J Kidney Dis 38: 1009-1015, 2001.","DOI":"10.1053\/ajkd.2001.28590"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Ray L, Nanda SK, Chatterjee A, Sarangi R, Ganguly S. A comparative study of serum aminotransferases in chronic kidney disease with and without end-stage renal disease: need for new reference ranges. Int J Appl Basic Med Res 5: 31-35, 2015.","DOI":"10.4103\/2229-516X.149232"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Wolf PL, Williams D, Coplon N, Coulson AS. Low aspartate transaminase activity in serum of patients undergoing chronic hemodialysis. Clin Chem 18: 567-568, 1972.","DOI":"10.1093\/clinchem\/18.6.567"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Rej R, Fasce CF Jr, Vanderlinde RE. Increased aspartate aminotransferase activity of serum after <i>in vitro<\/i> supplementation with pyridoxal phosphate. Clin Chem 19: 92-98, 1973.","DOI":"10.1093\/clinchem\/19.1.92"},{"key":"29","unstructured":"29. Ono K, Ono T, Matsumata T. The pathogenesis of decreased aspartate aminotransferase and alanine aminotransferase activity in the plasma of hemodialysis patients: the role of vitamin B6 deficiency. Clin Nephrol 43: 405-408, 1995."}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/62\/18\/62_2115-23\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,16]],"date-time":"2023-09-16T03:24:10Z","timestamp":1694834650000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/62\/18\/62_2115-23\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,15]]},"references-count":29,"journal-issue":{"issue":"18","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.2115-23","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,15]]},"article-number":"2115-23"}}